NEW YORK (GenomeWeb) – ACT Genomics today announced it has raised more than $8 million in its first private funding round.

The funds will support further investment in the firm's lineup of molecular diagnostic assays for monitoring cancer and expansions in the firm's sales, marketing, and medical teams.

"The additional capital will allow us to continue building robust molecular assays and [an] innovative bioinformatics engine," ACT Genomics CEO Hua-Chien Chen said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.